Department of Infectious Disease and Clinical Microbiology
| Registry | NCT05650944 |
|---|---|
| Status | Completed |
| Study type | Observational |
| Enrollment | 125 (Actual) |
| Sponsor | Hisar Intercontinental Hospital (Other) |
| Conditions | COVID-19 |
| Interventions | Hemogram (Diagnostic test) |
| Dates | start 2020-03-01, primary completion 2021-12-31, completion 2022-09-30, first posted 2022-12-14, last updated 2022-12-14 |
| Locations | 1 site in Turkey (Türkiye) |
Related Papers Related Patents Related Grants Related Experts
All trials for COVID-19 All trials of Hemogram
It is aimed to reveal the treatment and prognostic values by evaluating the differences in hematological parameters and indices, especially in dead Covid-19 cases.
Material Method: It is planned to retrospectively examine the hemogram parameters of 125 male, 44 female and 169 critical Covid-19 patients hospitalized between 01.03.2020 and 31.12.2021. Subjects were divided into 2 groups as deceased (77) and living (92) patients according to demographic data such as age and gender.
Statistical evaluation: All analyzes were SPSS 25.0, Kolmogorov Smirnov test was used to determine distribution, median and interquartile range (Tukey's Hinges Percentile) were used to summarize variables. The differences between the Independent-Samples Mann Whitney U Test and the data of the patient groups and the optimal cut-off values, sensitivity and specificity values will be determined by ROC analysis. It will be considered statistically significant when the p value is below 0.05 (with the two-tailed test)
The aim of this study is to examine the effectiveness of routine laboratory complete blood count parameters and rates as diagnostic and prognostic criteria in severe COVID-19.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Covid-19 Survivor groups | Diagnostic Test: Hemogram | Covid-19 survivor groups are hematological parameters | |
| Covid-19 Non-survivor groups | Diagnostic Test: Hemogram | Hematological parameters in patients with severe COVID-19 who have died. |
Sex: All, ages: 18 Years to any
Inclusion Criteria: 1. Patients over the age of 18 2. Critical patients taken to intensive care 3. The length of stay in the ICU is more than 24 hours Exclusion Criteria: 1\) Patients under 18 years of age (2) Patients with hematological malignancies (3) The length of stay in the ICU is less than 24 hours.
| Facility | City | Country | Status |
|---|---|---|---|
| Hisar Hospital Intercontinental | Istanbul | Turkey (Türkiye) |